Efg Asset Management (North America) Corp. Ultragenyx Pharmaceutical Inc. Transaction History
Efg Asset Management (North America) Corp.
- $585 Million
- Q3 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 109,388 shares of RARE stock, worth $4.86 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
109,388
Previous 125,561
12.88%
Holding current value
$4.86 Million
Previous $5.16 Million
17.75%
% of portfolio
1.04%
Previous 0.91%
Shares
7 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$442 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$249 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$227 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$185 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$136 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.11B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...